WCPO: Cincinnati a hub for stroke research
WCPO highlighted the Steps for Stroke 2024 event, raising money to advance stroke research, including at the University of Cincinnati.
Bethany Moeddel, a two-time stroke survivor, participated in the event for the 12th time on March 17 and told WCPO her parents brought her to the University of Cincinnati because of its status as a world-class leader in stroke research and patient care.
The UC Gardner Neuroscience Institute has recently been renewed as the National Coordinating Center for NIH StrokeNet, overseeing all clinical trials and other federally funded stroke research across the country.
UC's Stacie Demel, DO, PhD, provided opening remarks at the Steps for Stroke event. She said while there has been great progress in preventing and treating strokes and in stroke rehabilitation, there is still more work to be done.
"My hope is that with ongoing research we'll be able to treat patients who weren't included in those initial studies," she told WCPO. "Maybe it's patients who have some disability at baseline who were included in those initial trials."
Featured photo at top of UC Health's mobile stroke unit courtesy of UC Health.
Remember how to identify a stroke
Because of the quick onset of stroke, it is important to know the FAST mnemonic device that details the most common signs of stroke and how to respond:
- F: Facial drooping
- A: Arm or leg drop, or weakness in the arm or leg
- S: Speech issues, such as slurred speech or an inability to get your words out
- T: Time is of the essence; call 911 immediately
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.